A randomized phase III trial comparing mitomycin-C plus short-term doxifluridine (Mf) versus mitomycin-C plus long-term doxifluridine plus cisplatin (MFP) after curative resection of advanced gastric cancer (AMC 0201) (NCT00296335)

被引：0
|
作者：
Chang, H.
Kang, Y.
Min, Y.
Zang, D.
Kim, G.
Yang, D.
Jang, S.
Yook, J.
Oh, S.
Kim, B.
机构：
[1] Asan Medcl Ctr, Seoul, South Korea
[2] Ulsan Univ Hosp, Ulsan, South Korea
[3] Hallym Univ, Sacred Heart Hosp, Anyang, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4531
引用
收藏
页数：1
相关论文
共 38 条
  • [1] Update of AMC 0201 Study - a Randomized Phase III Trial Comparing Mitomycin-C Plus Short-term Doxifluridine (Mf) Versus Mitomycin-C Plus Long-term Doxifluridine Plus Cisplatin (MFP) After Curative Resection of Advanced Gastric Cancer (NCT00296335)
    Min, Y. J.
    Kang, Y. K.
    Ryoo, B. Y.
    Zang, D. Y.
    Kim, G. Y.
    Yang, D. H.
    Jang, S. J.
    Yook, J. H.
    Oh, S. T.
    Kim, B. S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S462 - S462
  • [2] Update of AMC 0201 study: A randomized phase III trial comparing mitomycin-C plus short-term doxifluridine (Mf) versus mitomycin-C plus long-term doxifluridine plus cisplatin (MFP) after curative resection of advanced gastric cancer (NCT00296335).
    Ryoo, Baek-Yeol
    Kang, Yoon-Koo
    Min, Young Joo
    Zang, Dae Young
    Kim, Gyu Yeol
    Yang, Dae Hyun
    Jang, Se Jin
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Postoperative adjuvant chemotherapy for grossly serosa-positive advanced gastric cancer: A randomized phase III trial of intraperitoneal cisplatin and early mitomycin-C plus long-term doxifluridine plus cisplatin (iceMFP) versus mitomycin-C plus short-term doxifluridine (Mf) (AMC 0101) (NCT00296322)
    Kang, Y.
    Chang, H.
    Zang, D.
    Lee, J.
    Kim, T.
    Yang, D.
    Jang, S.
    Yook, J.
    Oh, S.
    Kim, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Update of AMC 0101 study: A phase III trial of intraperitoneal cisplatin and early mitomycin-C plus long-term doxifluridine plus cisplatin (iceMFP) versus mitomycin-C plus short-term doxifluridine (Mf) as adjuvant chemotherapy for grossly serosa-positive advanced gastric cancer (NCT00296322).
    Kang, Yoon-Koo
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    Zang, Dae Young
    Kim, Tae Won
    Yang, Dae Hyun
    Jang, Se Jin
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [5] Update of AMC 0101 Study - a Randomized Phase III Trial of Intraperitoneal Cisplatin and Early MItomycin-C Plus Long-term Doxifluridine Plus Cisplatin (iceMFP) Versus Mitomycin-C Plus Short-Term Doxifluridine (Mf) as Postoperative Adjuvant Chemotherapy for Grossly Serosa-positive Advanced Gastric Cancer (NCT00296322)
    Kang, Y. K.
    Ryu, M. H.
    Chang, H. M.
    Zang, D. Y.
    Kim, T. W.
    Yang, D. H.
    Jang, S. J.
    Yook, J. H.
    Oh, S. T.
    Kim, B. S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S443 - S444
  • [6] Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)
    Kang, Y-K
    Chang, H-M
    Yook, J. H.
    Ryu, M-H
    Park, I.
    Min, Y. J.
    Zang, D. Y.
    Kim, G. Y.
    Yang, D. H.
    Jang, S. J.
    Park, Y. S.
    Lee, J-L
    Kim, T. W.
    Oh, S. T.
    Park, B. K.
    Jung, H-Y
    Kim, B. S.
    BRITISH JOURNAL OF CANCER, 2013, 108 (06) : 1245 - 1251
  • [7] Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)
    Y-K Kang
    H-M Chang
    J H Yook
    M-H Ryu
    I Park
    Y J Min
    D Y Zang
    G Y Kim
    D H Yang
    S J Jang
    Y S Park
    J-L Lee
    T W Kim
    S T Oh
    B K Park
    H-Y Jung
    B S Kim
    British Journal of Cancer, 2013, 108 : 1245 - 1251
  • [8] Randomized phase II study comparing mitomycin, cisplatin plus doxifluridine with cisplatin plus doxifluridine in advanced unresectable gastric cancer
    Koizumi, W
    Fukuyama, Y
    Fukuda, T
    Akiya, T
    Hasegawa, K
    Kojima, Y
    Ohn, N
    Kurihara, M
    ANTICANCER RESEARCH, 2004, 24 (04) : 2465 - 2470
  • [9] A COOPERATIVE RANDOMIZED STUDY ON TEGAFUR PLUS MITOMYCIN-C VERSUS COMBINED TEGAFUR AND URACIL PLUS MITOMYCIN-C IN THE TREATMENT OF ADVANCED GASTRIC-CANCER
    KURIHARA, M
    IZUMI, T
    YOSHIDA, S
    OHKUBO, T
    SUGA, S
    KIYOHASHI, A
    YAOSAKA, T
    TAKAHASHI, H
    ITO, T
    SASAI, T
    AKIYA, T
    AKAZAWA, S
    BETSUYAKU, T
    TAGUCHI, S
    JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (05): : 613 - 620
  • [10] Single immediate preoperative instillation of electromotive mitomycin-C plus transurethral resection versus transurethal resection alone versus transurethral resection plus immediate mitomycin-C for pTa bladder tumors: Long term results of a prospective randomized trial
    Di Stasi, Savino M.
    Storti, Luigi
    Giurioli, Arcangelo
    Brausi, Maurizio
    Capelli, Giovanni
    Zampa, Germano
    Stephen, Robert L.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 585 - 585
1234